| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Akiyoshi Fukamizu | Q88081774 |
| Mitsuko Furuya | Q88546634 | ||
| Ichiro Aoki | Q122928770 | ||
| Junji Ishida | Q122928774 | ||
| P2860 | cites work | An essential role for angiotensin II type 1a receptor in pregnancy-associated hypertension with intrauterine growth retardation | Q75197234 |
| Human spiral artery renin-angiotensin system | Q77418886 | ||
| Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry | Q77551341 | ||
| The localization and expression of the renin-angiotensin system in the human placenta throughout pregnancy | Q78039553 | ||
| Association of a variant of the angiotensinogen gene with pure type of hypertension in pregnancy in the Japanese: implication of a racial difference and significance of an age factor | Q78247581 | ||
| Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-beta signaling | Q79291122 | ||
| Expression of kallikrein, bradykinin b2 receptor, and endothelial nitric oxide synthase in placenta in normal gestation, preeclampsia, and placenta accreta | Q80193123 | ||
| Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition | Q80376810 | ||
| Differential roles of renin and angiotensinogen in the feto-maternal interface in the development of complications of pregnancy | Q81369402 | ||
| Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature | Q81423834 | ||
| Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia | Q22254337 | ||
| Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor | Q24320710 | ||
| Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? | Q24561702 | ||
| Targeting HIF-1 for cancer therapy | Q27860504 | ||
| Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review | Q28175314 | ||
| CD105 is important for angiogenesis: evidence and potential applications | Q28207439 | ||
| Soluble endoglin contributes to the pathogenesis of preeclampsia | Q28244053 | ||
| Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation. Arterial, intracardiac, and venous blood flow velocity studies | Q28304543 | ||
| Transforming growth factor-beta expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction | Q28363404 | ||
| Profile of neurokinin B concentrations in maternal and cord blood in normal pregnancy | Q29040192 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Placental development: lessons from mouse mutants | Q29618167 | ||
| EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF | Q29619098 | ||
| Basement membranes: structure, assembly and role in tumour angiogenesis | Q29622882 | ||
| An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis | Q30480495 | ||
| Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer. | Q32046234 | ||
| Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility | Q32075112 | ||
| Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer | Q33369361 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry | Q33874221 | ||
| Immunology of placentation in eutherian mammals | Q33997922 | ||
| Current topic: the uteroplacental renin-angiotensin system | Q34001273 | ||
| Mechanical stress-initiated signal transductions in vascular smooth muscle cells | Q34034099 | ||
| Angiogenesis in the placenta | Q34190112 | ||
| Neurokinin B peptide serum levels are higher in normotensive pregnant women than in preeclamptic pregnant women | Q34278621 | ||
| Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study | Q40802999 | ||
| HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells | Q40868181 | ||
| The influence of donated gametes on the incidence of hypertensive disorders of pregnancy | Q43643362 | ||
| Endothelin converting enzyme (ECE) activity in normal pregnancy and preeclampsia | Q44627739 | ||
| Trophoblast pseudo-vasculogenesis: faking it with endothelial adhesion receptors | Q46258674 | ||
| Impaired placental neovascularization in mice with pregnancy-associated hypertension | Q46337204 | ||
| Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach | Q46340721 | ||
| Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family | Q46418228 | ||
| Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness | Q46841539 | ||
| Mechanisms of hypertension associated with BAY 43-9006. | Q46919074 | ||
| Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia | Q47915288 | ||
| How Does the maternal immune system contribute to the development of pre-eclampsia? | Q48545136 | ||
| Surface expression of HLA-C antigen by human extravillous trophoblast | Q48563468 | ||
| Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. | Q51037240 | ||
| Endovascular trophoblast invasion, spiral artery remodelling and uteroplacental haemodynamics in a transgenic rat model of pre-eclampsia. | Q51701103 | ||
| Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function. | Q52009056 | ||
| Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. | Q52547834 | ||
| Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. | Q53600812 | ||
| Dysregulation of the Circulating and Tissue-Based Renin-Angiotensin System in Preeclampsia | Q56981959 | ||
| Decidual NK Cells Alter In Vitro First Trimester Extravillous Cytotrophoblast Migration: A Role for IFN- | Q58328312 | ||
| Predicting the risk of pre-eclampsia and a small-for-gestational-age infant by quantitative assessment of the diastolic notch in uterine artery flow velocity waveforms in unselected women. | Q64980885 | ||
| Tissue levels of active and total renin, angiotensinogen, human chorionic gonadotropin, estradiol, and progesterone in human placentas from different methods of delivery | Q69506725 | ||
| Determination of renin, angiotensin converting enzyme and angiotensin II levels in human placenta, chorion and amnion from women with pregnancy induced hypertension | Q71254944 | ||
| Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen | Q71695937 | ||
| Angiotensin-II stimulates estradiol secretion from human placental explants through AT1 receptor activation | Q72149716 | ||
| Human uterine decidual macrophages express renin | Q72149739 | ||
| Production of prostacyclin and thromboxane A2 in mononuclear cells from preeclamptic women | Q72602386 | ||
| Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension | Q73128397 | ||
| Cross-sectional and longitudinal evaluation of uterine artery Doppler velocimetry for the prediction of pre-eclampsia in normotensive women with specific risk factors | Q73775151 | ||
| Pathophysiology of pregnancy-induced hypertension | Q74039094 | ||
| Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy | Q74090763 | ||
| Latest advances in understanding preeclampsia | Q34425288 | ||
| A study of angiotensin II pressor response throughout primigravid pregnancy | Q34512573 | ||
| Physiology of local renin-angiotensin systems. | Q34543927 | ||
| Comparative developmental anatomy of the murine and human definitive placentae. | Q34546263 | ||
| G-protein-coupled receptors and cancer. | Q34606002 | ||
| Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry | Q34979775 | ||
| Minireview: overview of the renin-angiotensin system--an endocrine and paracrine system | Q35127232 | ||
| Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma | Q35141769 | ||
| Pre-eclampsia, the placenta and the maternal systemic inflammatory response--a review | Q35169648 | ||
| Trophoblastic remodeling in normal and preeclamptic pregnancies: implication of cytokines. | Q35172646 | ||
| Angiogenesis and vasculogenesis in pregnancy | Q35215691 | ||
| Control of vascular resistance in the human placenta | Q35531114 | ||
| Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling | Q35681804 | ||
| Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy | Q35699115 | ||
| Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome | Q35750283 | ||
| Molecular determinants of ovarian cancer plasticity | Q35842085 | ||
| Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question | Q35920602 | ||
| Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide | Q36080082 | ||
| Priming and remodelling of human placental bed spiral arteries during pregnancy--a review | Q36100924 | ||
| Animal models of placental angiogenesis | Q36286797 | ||
| Preeclampsia: recent insights | Q36288757 | ||
| New insights into the biology of preeclampsia | Q36371864 | ||
| Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success | Q36399286 | ||
| The uterine spiral arteries in human pregnancy: facts and controversies | Q36401771 | ||
| Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics | Q36418785 | ||
| Pathophysiology of tumor neovascularization | Q36742274 | ||
| Dialogue between blastocyst hCG and endometrial LH/hCG receptor: which role in implantation? | Q36970050 | ||
| Cancer neovascularization and proinflammatory microenvironments | Q37184766 | ||
| Angiotensinogen T235 expression is elevated in decidual spiral arteries | Q37372462 | ||
| Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants | Q37377636 | ||
| Angiotensin II levels in hypertensive and normotensive pregnancies | Q37664263 | ||
| Cell migration activated by platelet-derived growth factor receptor is blocked by an inverse agonist of the sphingosine 1-phosphate receptor-1. | Q40345678 | ||
| Agonist-induced interactions between angiotensin AT1 and epidermal growth factor receptors. | Q40419921 | ||
| Endoglin regulates nitric oxide-dependent vasodilatation | Q40597391 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | placenta development | Q1114520 |
| pathophysiology | Q1135939 | ||
| placenta | Q1212935 | ||
| hypertensive disease of pregnancy | Q19001368 | ||
| placental circulation | Q71151469 | ||
| P304 | page(s) | 1301-1313 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Vascular Health and Risk Management | Q7916443 |
| P1476 | title | Pathophysiology of placentation abnormalities in pregnancy-induced hypertension | |
| P478 | volume | 4 |
| Q27025652 | ART and health: clinical outcomes and insights on molecular mechanisms from rodent studies |
| Q35933436 | Alcohol use disorders in pregnancy |
| Q36901631 | Association of early-preterm birth with abnormal levels of routinely collected first- and second-trimester biomarkers |
| Q35965384 | Associations between ambient air pollution and Hypertensive Disorders of Pregnancy |
| Q64238178 | Case Report: Optical Coherence Tomography Can Find Typical Features in Pregnancy-induced Hypertension with Retinopathy |
| Q58101092 | Clarification and confocal imaging of the nonhuman primate placental micro-anatomy |
| Q89801374 | Differential DNA Methylation in Placenta Associated With Maternal Blood Pressure During Pregnancy |
| Q34731047 | Disrupted balance of angiogenic and antiangiogenic signalings in preeclampsia |
| Q37016826 | Fetal sex-related dysregulation in testosterone production and their receptor expression in the human placenta with preeclampsia |
| Q35956397 | Lack of Thromboxane Synthase Prevents Hypertension and Fetal Growth Restriction after High Salt Treatment during Pregnancy |
| Q93156154 | Molecular Targets of Aspirin and Prevention of Preeclampsia and Their Potential Association with Circulating Extracellular Vesicles during Pregnancy |
| Q58911048 | Molecular mechanisms of preeclampsia |
| Q34359647 | Monocyte subpopulations from pre-eclamptic patients are abnormally skewed and exhibit exaggerated responses to Toll-like receptor ligands |
| Q36190273 | New frontiers in heart hypertrophy during pregnancy. |
| Q26746049 | No Hypertensive Disorder of Pregnancy; No Preeclampsia-eclampsia; No Gestational Hypertension; No Hellp Syndrome. Vascular Disorder of Pregnancy Speaks for All |
| Q47348758 | Pregnancy outcomes in adult patients with dermatomyositis and polymyositis |
| Q26798340 | Regional changes of placental vascularization in preeclampsia: a review |
| Q87627434 | Relation of maternal hypertension with infant growth in a prospective birth cohort: the ABCD study |
| Q90248296 | Role of the NLRP3 Inflammasome in Preeclampsia |
| Q28397515 | TCDD induces the hypoxia-inducible factor (HIF)-1α regulatory pathway in human trophoblastic JAR cells |
| Q34082971 | The effects of hemodynamic force on embryonic development |
Search more.